The Role of Herbal Medicine in Cholangiocarcinoma Control: A Systematic Review
Planta Medica · 01.01.2023 · 89 (01) · 3-18
DOI: 10.1055/a-1676-9678 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Planta Medica, erschienen am 01.01.2023. Verfasst von Kesara Na-Bangchang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Center of Excellence in Pharmacology and Molecular Biology of Malaria and Cholangiocarcinoma, Chulabhorn International College of Medicine, Thammasat…. Hauptthemen laut MEDLINE: Plants, Medicinal, Cholangiocarcinoma, Atractylodes, Bile Duct Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 155 Literaturangaben. Gefördert von: 82-/63, NRCT National Research Council of Thailand.
Abstract (Originalsprache)
The growing incidence of cholangiocarcinoma (bile duct cancer) and limited treatment options stimulate a pressing demand for research and the development of new chemotherapeutics against cholangiocarcinoma. This study aimed to systematically review herbs and herb-derived compounds or herbal formulations that have been investigated for their anti-cholangiocarcinoma potential. Systematic literature searches were conducted in three electronic databases: PubMed, ScienceDirect, and Scopus. One hundred and twenty-three research articles fulfilled the eligibility critera and were included in the analysis (68 herbs, isolated compounds and/or synthetic analogs, 9 herbal formulations, and 119 compounds that are commonly found in several plant species). The most investigated herbs were Atractylodes lancea (Thunb.) DC. (Compositae) and Curcuma longa L. (Zingiberaceae). Only A. lancea (Thunb.) DC. (Compositae) has undergone the full process of nonclinical and clinical development to deliver the final product for clinical use. The extracts of A. lancea (Thunb.) DC. (Compositae), Garcinia hanburyi Hook.f. (Clusiaceae), and Piper nigrum L. (Piperaceae) exhibit antiproliferative activities against human cholangiocarcinoma cells (IC50 < 15 µg/mL). Cucurbitacin B and triptolide are herbal isolated compounds that exhibit the most promising activities (IC50 < 1 µM). A series of experimental studies (in vitro, in vivo, and humans) confirmed the anti-cholangiocarcinoma potential and safety profile of A. lancea (Thunb.) DC. (Compositae) and its active compounds atractylodin and β-eudesmol, including the capsule pharmaceutical of the standardized A. lancea (Thunb.) DC. (Compositae) extract. Future research should be focused on the full development of the candidate herbs to deliver products that are safe and effective for cholangiocarcinoma control.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center of Excellence in Pharmacology and Molecular Biology of Malaria and Cholangiocarcinoma, Chulabhorn International College of Medicine, Thammasat University (Rangsit Campus), Klongneung, Klongluang District, Pathumt…
- Drug Discovery and Development Center, Office of Advanced Science and Technology, Thammasat University (Rangsit Campus), Klongneung, Klongluang District, Pathumthani, Thailand.
Förderung
- 82-/63
- NRCT National Research Council of Thailand
Zitieren
APA
Na-Bangchang, K., Plengsuriyakarn, T., & Karbwang, J. (2023). The Role of Herbal Medicine in Cholangiocarcinoma Control: A Systematic Review. Planta Medica, 89(01), 3-18. https://doi.org/10.1055/a-1676-9678
Vancouver
Na-Bangchang K, Plengsuriyakarn T, Karbwang J. The Role of Herbal Medicine in Cholangiocarcinoma Control: A Systematic Review. Planta Medica. 2023;89(01):3-18. doi:10.1055/a-1676-9678
BibTeX
@article{NaBangchang2023,
author = {Na-Bangchang, Kesara and Plengsuriyakarn, Tullayakorn and Karbwang, Juntra},
title = {The Role of Herbal Medicine in Cholangiocarcinoma Control: A Systematic Review},
journal = {Planta Medica},
year = {2023},
volume = {89},
number = {01},
pages = {3--18},
doi = {10.1055/a-1676-9678}
}
EUVIMED